You are here
The day will see the launch of the partnerships ambitious five-year research strategy and showcase recent and future research across the partnership from clinicians and academics, taking place on 9th July 2024 at
The randomised control trial explored the use of Problem Adaptation Therapy (PATH) for individuals with mild to moderate dementia and depression and found that although benefits were not sustained after three mon
Thousands of people from NHS memory clinics are set to take part in countrywide study looking to capitalise on recent breakthroughs in potential dementia blood tests.
The team at Noclor and many of our colleagues in the research world and beyond have been saddened by the passing of Paul Wallace.
The latest National Institute of Health and Care Research (NIHR) funding calls includes Health Technology Assessment Programmes for Crohn's disease management, digital technologies in social care and a themed call on reducing compound pres
Improved treatments being researched for prostate cancer, the most common form of cancer in men, could be rolled out almost two years earlier than possible at present
Study conducted as part of PANORAMIC platform trial finds that the current recommended five-day course may not be the adequate length to treat COVID-19 infections
The innovative Cytosponge tool previously trialled in GP Practices is now reducing the long NHS waiting times experienced for endoscopies to diagnose precursor to cancer
When people experience long-term mental distress and difficulties coping with relationships it can reduce their quality of life and lead to social exclusion.
The new findings from the UCL led study found that the risk of developing Alzheimer’s disease was 18% less in men prescribed drugs commonly used to treat erectile dysfunction.